News

Cryptopolitan on MSN24m

Ruvi AI (RUVI) Might Be 2025’s Breakout Star Thanks to CMC Partnership, $1 Evaluations Seem Within Reach as Daily Sales Surpass Millions

If you’re hunting for asymmetric upside heading into 2025, Ruvi AI (RUVI) is building the kind of momentum that turns ...

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...